Crane Worldwide strengthens its global solutions for the safe delivery of the Covid-19 vaccine
With recent announcements that pharmaceutical companies are close to supplying an initial vaccine to combat the Covid-19 virus around the world, global logistics experts are stepping up to support what will be an epic supply chain challenge.
As the world watches closely, supply chain experts are exerting their knowledge and expertise and will play a critical role in distribution strategies to deliver the vaccine to end-users in rural and city locations.
Specific supply chain solutions encompassing the storage, international/domestic transportation, and final mile distribution methods of the Covid-19 vaccine will hinge upon the leading pharmaceutical companies’ final product specification that could include temperatures as cold as -70’C.
To this end Crane Worldwide has not only invested in temperature-controlled equipment, but has also invested in visibility and monitoring systems that will be used to provide end-to-end record keeping to meet industry and regulatory compliance, enable enhanced security, and provide the utmost quality assurance to global vaccine manufacturers, the company revealed in a recent press communiqué.
“Supply chain partnerships will be a critical success factor in the distribution of the COVID vaccine to communities all over the world,” commented Keith Winters, CEO, Crane Worldwide.
It is our moral duty, as a 3PL partner, to ensure that we have solid solutions in place when the vaccine is released. With a partnership approach, we will not only provide flexibility but also make further investment to support our client’s supply chain constraints both now, and in the future,” he added.